FinancialContent is the trusted provider of stock market information to the media industry.
Latest News about BioDelivery Sciences International, Inc/
BDSI expects $50 million in latest public offering
April 11, 2019
Stocks down in December for pharma firms in the Triangle
December 27, 2018
category NovoCure Limited , Fennec Pharmaceuticals Inc/ , United Therapeutics Corporation , and 20 more.
The most valuable public companies in the Triangle (Slideshow)
November 05, 2018
From Iqvia's Bousbib to Red Hat's Whitehurst: Who made the most from inside stock sales in 3Q2018
October 05, 2018
Some highs, lows as RTP biotech companies report earnings
August 10, 2018
Broadfin pumps $50M into Raleigh's BDSI
May 17, 2018
Raleigh pharma ushers in new CEO from Allergan
May 08, 2018
Raleigh pharma quadruples revenue, lands new contract
March 16, 2018
BDSI reaches settlement with generic drug giant Teva
February 07, 2018
category Teva Pharmaceutical Industries Ltd/ , Teva Pharmaceutical Industries Limited , BioDelivery Sciences International , and 2 more.
BDSI’s new president: We're expanding our sales force
December 22, 2017
category Health Care , BioDelivery Sciences International, Inc/ , BioDelivery Sciences International
BDSI names new president
December 20, 2017
category Health Care , BioDelivery Sciences International, Inc/ , Salix Pharmaceuticals , and 4 more.
These are the best-run public companies in the Triangle (Slideshow)
November 28, 2017
BDSI settles patent litigation with generic giant Teva
October 12, 2017
category Teva Pharmaceutical Industries Limited , Teva , BioDelivery Sciences International, Inc/ , and 2 more.
BDSI CEO to retire
August 23, 2017